• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL GMBH INTEGRA BOVINE PERICARDIUM DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL GMBH INTEGRA BOVINE PERICARDIUM DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT Back to Search Results
Lot Number NZ16300081
Device Problem Degraded (1153)
Patient Problems Cerebrospinal Fluid Leakage (1772); Headache (1880)
Event Date 09/06/2018
Event Type  Injury  
Manufacturer Narrative
A comprehensive re-review of records is being conducted with results not available at the time of this report.This review includes manufacturing records, sterilization reports, quality control / assurance review and release, and review of complaints database for related complaints for the lot.Once results are available, a follow up report will be submitted.
 
Event Description
Rti surgical, inc (rti) received a complaint on (b)(6) 2018 indicating that a patient was implanted with an integra bovine pericardium dural graft and developed a pseudomeningocele, requiring the graft to be replaced.The patient is a female with chiari malformation who underwent decompression in (b)(6) 2018.She developed headaches and posterior neck swelling in late (b)(6) 2018 from a pseudomeningocele.The patient was monitored for 2 weeks with a repeated mri showing an enlarging pseudomeningocele as well as worsening of symptoms.She was taken back to surgery on (b)(6) 2018 to repair the cerebrospinal fluid leak.Complete breakdown of the dural graft was noted during surgery.The graft was replaced utilizing a graft from a different manufacturer.Additional information has been requested.To date, rti has not received any additional information.
 
Manufacturer Narrative
A comprehensive re-review of manufacturing records was conducted.Bovine pericardium implants undergo a validated sterilization method; tutoplast® which includes terminal sterilization by gamma irradiation after packaging.There were two departures noted during records re-review.One departure indicated that the bioburden exceeded the action limit.The other departure indicated that the bioburden for the sodium chloride solution exceeded the action limit.Both departures did not affect the complaint graft since it was not part of the tutoplast batches affected by them.Manufacturing records indicate that serial id (b)(4) manufactured from lot nz16300081 met all specification requirements at the time of release.To date, rti/tmi has manufactured and distributed (b)(4) bovine pericardium implants from lot nz16300081 without related complaints for the lot.Based on our records re-review and "the" complaint information provided to date, it is more plausible that the patient's post-operative complications are associated with an event or source extrinsic to the xenograft implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTEGRA BOVINE PERICARDIUM DURAL GRAFT
Type of Device
BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT
Manufacturer (Section D)
TUTOGEN MEDICAL GMBH
indrustriestr 6
neunkirchen am brand, 91077
GM  91077
MDR Report Key7986364
MDR Text Key124490923
Report Number3002719998-2018-00012
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
PMA/PMN Number
K132850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Type of Report Initial,Followup
Report Date 02/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date03/31/2022
Device Lot NumberNZ16300081
Was Device Available for Evaluation? No
Date Manufacturer Received09/21/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-